Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

1.6000

0.0000

(0.00%)

At close: 04:00PM EDT

1.5500

-0.05

(-3.12%)

After hours:

07:38PM EDT

Major Holders

Insider Roster

Insider Transactions

Currency in USD

Insider Purchases Last 6 Months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net Shares Purchased (Sold)	0	0
Total Insider Shares Held	16.57M	N/A
% Net Shares Purchased (Sold)	N/A	N/A

Net Institutional Purchases Prior Quarter to Latest Quarter	Shares
Net Shares Purchased (Sold)	N/A
% Change in Institutional Shares Held	N/A

Insider Transactions Reported - Last Two Years

Insider	Transaction	Type	Value	Date	Shares
SCHUETZ THOMAS J Officer and Director	Stock Award(Grant) at price 1.93 per share.	Direct	1,230,375	Jan 09, 2024	637,500
BISKER-LEIB VERED Chief Executive Officer	Stock Award(Grant) at price 1.93 per share.	Direct	3,383,531	Jan 09, 2024	1,753,125
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.37 per share.	Direct	33,700	Mar 10, 2023	10,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.98 per share.	Direct	79,600	Feb 27, 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.86 per share.	Direct	77,200	Feb 15, 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	Feb 08, 2023	500,000
BISKER-LEIB VERED Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	Feb 08, 2023	400,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 4.05 per share.	Direct	81,000	Jan 31, 2023	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 4.19 per share.	Direct	83,800	Jan 24, 2023	20,000
BISKER-LEIB VERED Chief Operating Officer	Sale at price 4.19 - 4.36 per share.	Direct	103,708	Nov 25, 2022	24,500
BISKER-LEIB VERED Chief Operating Officer	Sale at price 4.34 - 4.40 per share.	Direct	96,986	Nov 21, 2022	22,261
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.25 per share.	Indirect	1,708,500	Nov 08, 2022	402,000
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 4.25 per share.	Indirect	1,708,500	Nov 08, 2022	402,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.32 per share.	Direct	23,200	Sept 28, 2022	10,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.27 per share.	Direct	34,050	Sept 26, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.03 per share.	Direct	45,450	Sept 07, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.83 per share.	Direct	42,450	Sept 01, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.05 per share.	Direct	45,750	Aug 17, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.64 per share.	Direct	39,600	Aug 10, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.58 per share.	Direct	38,700	Aug 01, 2022	15,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.80 per share.	Direct	56,000	Jun 21, 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.34 per share.	Direct	46,800	Jun 16, 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.29 per share.	Direct	68,700	Jun 13, 2022	30,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.83 per share.	Direct	84,900	Jun 06, 2022	30,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.03 per share.	Direct	60,600	Jun 01, 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 3.04 per share.	Direct	60,800	May 26, 2022	20,000
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.72 per share.	Direct	49,926	May 23, 2022	18,355
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 2.47 per share.	Direct	49,931	May 17, 2022	20,215
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.79 - 2.49 per share.	Indirect	420,482	May 13, 2022	192,516
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.79 - 2.49 per share.	Indirect	420,482	May 13, 2022	192,516
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.56 - 1.63 per share.	Indirect	197,252	May 10, 2022	125,359
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 1.56 - 1.63 per share.	Indirect	197,252	May 10, 2022	125,359
SCHUETZ THOMAS J Chief Executive Officer	Purchase at price 1.80 per share.	Direct	50,105	May 10, 2022	27,836
SCHUETZ THOMAS J Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	Nov 16, 2021	600,000
BISKER-LEIB VERED Chief Operating Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	Nov 16, 2021	600,000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.50 per share.	Indirect	18,750,000	Nov 04, 2021	5,357,143
GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.50 per share.	Indirect	18,750,000	Nov 04, 2021	5,357,143

S&P/TSX22,465.37+165.54(+0.74%)

S&P 5005,303.27+6.17(+0.12%)

DOW40,003.59+134.21(+0.34%)

CAD/USD0.7348+0.0002(+0.03%)

CRUDE OIL80.00+0.77(+0.97%)

Bitcoin CAD91,421.54+1,209.88(+1.34%)

Compass Therapeutics, Inc. (CMPX)

Insider Transactions

Insider Transactions Reported - Last Two Years

S&P/TSX
22,465.37
+165.54(+0.74%)

S&P 500
5,303.27
+6.17(+0.12%)

DOW
40,003.59
+134.21(+0.34%)

CAD/USD
0.7348
+0.0002(+0.03%)

CRUDE OIL
80.00
+0.77(+0.97%)

Bitcoin CAD
91,421.54
+1,209.88(+1.34%)